Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04065269
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2019-08-01
Brief Title:
ATr Inhibitor in Combination With OlaparibDurvalumab MEDI4736 in Gynaecological Cancers With ARId1A Loss or no Loss
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Organization Data
Organization:
Institute of Cancer Research United Kingdom
Class:
OTHER
Study ID:
ICR-CTSU201810066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute of Cancer Research United Kingdom
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |
| Cancer Research UK | OTHER |